Aethlon Medical, Inc. (AEMD)
$2.64-3.30%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2M
- Avg volume
- 99.8K
- Beta
- 1.44
- P/E (TTM)
- -0.23
- Shares short
- 231.7K
- Days to cover
- 1.4
- SI change
- +1.4%
- 1W
- -10.20%
- 1M
- -9.59%
- 3M
- -76.00%
- YTD
- -81.28%
- vs SPY 1W
- -9.01%
- vs SPY 1M
- -12.91%
- vs SPY 3M
- -78.39%
- vs SPY YTD
- -93.03%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AMRNBUYAmarin Corporation plcRECOVERYQ 2$13.84-1.77%
- DNTHBUYDianthus Therapeutics, Inc.BULLQ 4$110.07-0.93%
- IMTXSELLImmatics N.V.CRISISQ 8$8.69-2.69%
- BRTXSELLBioRestorative Therapies, Inc.CRISISQ -14$0.21-4.55%
- SCLXSELLScilex Holding CompanyCRISISQ -22$5.66-1.22%
- GILDBUYGilead Sciences, Inc.RECOVERYQ 23$146.74+0.42%
- HCMBUYHUTCHMED (China) LimitedRECOVERYQ 4$12.18-3.56%
- BFLYBUYButterfly Network, Inc.RECOVERYQ 12$8.95-6.28%
- SENSBUYSenseonics Holdings, Inc.RECOVERYQ 4$9.38-3.40%
- VTAKSELLCatheter Precision, Inc.CRISISQ -30$0.21+0.00%
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- LCTXSELLLineage Cell Therapeutics, Inc.RECOVERYQ 11$1.09+0.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 22
- GROWTH
- 51
- GARP
- 5
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-73.9%
REV YoY-
ROE-30.1%
EPS YoY-
ROA-111.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.23
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B0.20
P/FCF-
EV/EBITDA0.50
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E4.91
ALTMAN Z-
CURR RATIO5.42
ND/EBITDA-
BETA1.44
NET INCOME (TTM) < 0
